Ruiyun Xu
- Molecular Biology
- Hepatology top 5%
- Surgery
- Cancer Research top 10%
- Epidemiology
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (12 papers)Liver physiology and pathology (10 papers)Liver Disease and Transplantation (7 papers)
- Cited by
- HepatologyCancer ResearchGenetics
- Partner nations
- ChinaUnited States
In The Last Decade
Ruiyun Xu
36 papers receiving 740 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 334
- Hepatology 260
- Surgery 191
- Cancer Research 187
- Epidemiology 151
Countries citing papers authored by Ruiyun Xu
This map shows the geographic impact of Ruiyun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiyun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiyun Xu more than expected).
Fields of papers citing papers by Ruiyun Xu
This network shows the impact of papers produced by Ruiyun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiyun Xu. The network helps show where Ruiyun Xu may publish in the future.
Co-authorship network of co-authors of Ruiyun Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ruiyun Xu. A scholar is included among the top collaborators of Ruiyun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiyun Xu. Ruiyun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 11 | |
| 3 | 13 | |
| 4 | 17 | |
| 5 | 97 | |
| 6 | 34 | |
| 7 | 14 | |
| 8 | 49 | |
| 9 | 13 | |
| 10 | 36 | |
| 11 | 10 | |
| 12 | 2 | |
| 13 | Precautionary effect on the early application of anticoagulant drugs to portal vein thrombosis in patients with portal hypertension after operation. | 1 |
| 14 | 53 | |
| 15 | 10 | |
| 16 | 24 | |
| 17 | 50 | |
| 18 | 8 | |
| 19 | 4 | |
| 20 | 28 |
About Ruiyun Xu
Ruiyun Xu is a scholar working on Hepatology, Cancer Research and Speech and Hearing, having authored 36 papers that have together received 745 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver physiology and pathology (10 papers) and Liver Disease and Transplantation (7 papers). The work is most often cited by research in Hepatology (260 citations), Cancer Research (187 citations) and Genetics (98 citations). Ruiyun Xu has collaborated with scholars based in China and United States. Frequent co-authors include Nan Lin, Mingxing Xu, Kunpeng Hu, Weidong Pan, Meihai Deng, Zhicheng Yao, Yi Lü, Yanjie Li, Si Chen and Yi Zhang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Hepatology and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.